Latest news
The Oral GLP-1 Tracker: Lilly's Foundayo builds scripts after disappointing Q2 - Fierce PharmaFierce Pharma · Sat, 08 Aug 2026 09:32:14 GMTOral Weight Loss Pill Helps Patients Lose up to 12% of Body Weight - SciTechDailySciTechDaily · Fri, 07 Aug 2026 18:12:52 GMTShifting GLP-1 research and development: Lessons learned from the first-generation - drugdiscoverytrends.comdrugdiscoverytrends.com · Fri, 07 Aug 2026 17:18:36 GMTLilly Files Its GLP-1 Pill for Diabetes, and the Manufacturing Case Is Stronger Than the Access Case - Medical DailyMedical Daily · Thu, 06 Aug 2026 12:00:14 GMTOral GLP-1 drugs may turn down the brain’s food craving circuit - diabetes.co.ukdiabetes.co.uk · Thu, 06 Aug 2026 02:17:24 GMTLLY Looks 19.8% Undervalued on GF Value™ as Oral GLP-1 Sales Imp - GuruFocusGuruFocus · Thu, 06 Aug 2026 00:29:15 GMTAscletis Initiates Global Phase III Trial for Oral GLP-1 Obesity Drug ASC30 - BioPharma APACBioPharma APAC · Wed, 05 Aug 2026 19:21:41 GMTLilly outperforms in bid to unseat Novo’s lead in oral GLP-1 market - Seeking AlphaSeeking Alpha · Wed, 05 Aug 2026 18:48:44 GMT